PHIBRO ANIMAL HEALTH CORP
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
Phone 201-329-7300
Fiscal Year End 0630
EIN 131840497
Financial Overview
FY2025
$48.26M
Net Income
$1.36B
Total Assets
$1.08B
Total Liabilities
$1.19
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 19, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 4 Insider stock transaction report | February 26, 2026 | View on SEC |
| 4 Insider stock transaction report | February 23, 2026 | View on SEC |
| 4 Insider stock transaction report | February 18, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| 4 Insider stock transaction report | February 11, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 11, 2026 | View on SEC |
Material Events
8-K Leadership Change December 18, 2025
High Impact
- Jack C. Bendheim is stepping down as CEO and President of Phibro Animal Health Corp.
- His son, Daniel (Dani) Bendheim, will be taking over as the new CEO and President.
Insider Trading
STRONG SELL 1 insiders
59 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.